Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-12-22

Clinical Trial Update: A Study of Caffeine on Cardiac Arrhythmias [NA]

View source ↗

Summary

A completed clinical trial investigates the effects of caffeine on supraventricular tachycardia and atrial fibrillation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Caffeine (caffeine)

Snippet

Sponsor: Ottawa Heart Institute Research Corporation | Conditions: Supraventricular Tachycardia (SVT), Atrial Fibrillation | NA | Status: COMPLETED